Thurston Springer Miller Herd & Titak’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-241
Closed -$24.5K 1354
2025
Q4
$24.5K Buy
241
+200
+488% +$16.1K 0.01% 689
2025
Q3
$2.24K Sell
41
-327
-89% -$16.3K ﹤0.01% 472
2025
Q2
$19.6K Buy
368
+55
+18% +$2.79K ﹤0.01% 948
2025
Q1
$13.5K Sell
313
-205
-40% -$10.4K ﹤0.01% 1007
2024
Q4
$29.1K Buy
518
+76
+17% +$4.73K 0.01% 642
2024
Q3
$30.1K Buy
442
+80
+22% +$4.51K 0.01% 703
2024
Q2
$15.3K Buy
+362
New +$19.9K ﹤0.01% 875

Other funds holding EXAS

Thurston Springer Miller Herd & Titak's EXAS Position: Q1 2026 in Review

Thurston Springer Miller Herd & Titak sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 241 shares — an estimated $24.5K sold.

Thurston Springer Miller Herd & Titak first reported a position in EXAS in Q2 2024 and held it in 7 quarters. The position peaked at $30.1K in Q3 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Thurston Springer Miller Herd & Titak reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Thurston Springer Miller Herd & Titak sold 241 Exact Sciences shares in Q1 2026, an estimated $24.5K.
  • Thurston Springer Miller Herd & Titak first reported a position in Exact Sciences in Q2 2024 and held it in 7 quarters.
  • Thurston Springer Miller Herd & Titak's Exact Sciences position peaked at $30.1K in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q1 2026, filed 14 Apr 2026.